Fogal et al. (2010) found that knocking down C1QBP expression in human cancer cells strongly shifted their metabolism from oxidative OXPHOS to glycolysis. C1QBP deficiency resulted in less in vivo tumorigenicity, probably due to the reduced synthesis of the mitochondrial-DNA-encoded OXPHOS polypeptides. This evidence concerns the gene C1QBP and cancer.